Tauriga Sciences, Inc. (OTCQB: TAUG) Soars 78% After Officially Launching E-Commerce Site for its CBD-Infused Chewing Gum, Tauri-Gum

Tauri Gum

Tauriga Sciences, Inc. (OTCQB: TAUG) operates as a business development company that focuses on the distribution and licensing of proprietary products. Shares of the business development company are surging 77.78%, through late trading on Tuesday, March 12, 2019. Over the past month, Tauriga Sciences, Inc. has seen average daily volume of 277,141 shares. However, volume of 1.86 million shares or…

Read More

Sino United and Sinoway Inl Corp. Sign MOU to Launch AutoCoin Security Tokens and Integrative Trading Platform for Trillion-Dollar Automotive Industry with Aims to Revolutionize the Industry Trading System and Push for ICO in Early 2019

SUIC SINO UNITED WORLDWIDE

NEW YORK, Dec. 12, 2018 Sino United Worldwide Consolidated Ltd. (OTC: SUIC) has signed the Memorandum of Understanding with Sinoway International Corp. for joint investment that will create a universal platform for buying and selling vehicles and auto related products or services by using its own cryptocurrency, the AutoCoin, and future cooperation with crypto ATM manufacturers. AutoCoin is a hybrid…

Read More

Q BioMed Announces Strategic Partnership with SRI International for Formulation and Preclinical Development of QBM-001 for Pediatric Nonverbal Disorder in Autistic Children

Collaboration with SRI Provides QBioMed Expertise in Formulation Development and Preclinical Work in Autism, as well as CMC and Manufacturing capability NEW YORK, December 12, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce a collaborative agreement with SRI International to provide formulation development, preclinical development, and early clinical manufacturing of QBM-001, in support…

Read More

Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare

Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in Which Metastron™ is Already Registered and Approved for Sale NEW YORK, November 28, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that it has entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron™,…

Read More